2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Urethral Cancer
Urethral cancer is a rare form of cancer that develops in the urethra, the tube that carries urine from the bladder out of the body. Research on urethral cancer is challenging due to its rarity and diverse subtypes, including squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma. Current studies focus on understanding the molecular mechanisms underlying urethral cancer development, exploring targeted therapies, and improving early detection methods. Advances in genomic profiling have provided insights into the genetic alterations driving urethral cancer, paving the way for personalized treatment approaches. Additionally, clinical trials are evaluating novel immunotherapy agents and combination therapies to enhance treatment outcomes. Despite the challenges, ongoing research efforts offer hope for improved management and outcomes for individuals affected by urethral cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China